Home / Chemicals / Hyaluronic

Hyaluronic Acid Market By Product Analysis (Product Type, Single Injection, Three Injection, Five Injection), Application Analysis (Application Type, Dermal Fillers, Adhesive Prevention, Osteoarthritis) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

The study covers the basic overview of the hyaluronic acid market, such as introduction, classification, and supply chain. In addition, to understand the market's competitiveness, porter's five force analysis is also included.The study provides a decisive view of the hyaluronic acid market by segmenting it based on regional demand, product type, and applications. Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, and RoW.

These have been further sub-segmented into countries' relevance to the market. By-product types include single Injections, three Injections, and five Injections. Based on applications, the market is segmented by vesicoureteral reflux, dermal fillers, adhesive prevention, and osteoarthritis.

This study also covers the factors driving and restraining the market dynamics with their impact during the forecast period. Furthermore, to provide a comprehensive view of the market, the study includes profiling key players such as Allergan Inc., Seikagaku, Ferring Pharmaceuticals, Sanofi Inc., Anika Therapeutics Inc., AstraZeneca, and Ferring Pharmaceuticals, among others.

The application segments covered in the study include vesicoureteral reflux, dermal fillers, adhesive prevention and osteoarthritis. Dermal fillers are the largest application segment for hyaluronic acid. It accounted for 37% share of the market in 2014 in terms of revenue. In 2014, the consumption of hyaluronic acid in dermal filler was USD 1.16 billion. The vesicoureteral reflux segment is projected to be the highest growth segment of the market.

Based on geography, the global hyaluronic acid market is segmented into following regions

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • Rest of RoW

North America is the largest market and accounted for 38% market share in 2014. The market is primarily enhanced by the growing geriatric population and their treatment needs. Therefore, North America is projected to maintain its dominance during the forecast period. Asia Pacific is projected to be the fastest growing market at a CAGR of 10.1% from 2015 to 2022. Growing awareness among the population and enhancement in health care infrastructure is the major factor contributing to market growth. RoW is another lucrative market for hyaluronic acid.

Frequently Asked Questions:

The market for Hyaluronic Acid is expected to reach USD 1.16 billion in 2022.

The Hyaluronic Acid market is expected to see significant CAGR growth over the coming years, at 9.7%.

The report is forecasted from 2015-2022

The base year of this report is 2014.

The Legrand S.A., Atkore International Holdings Ltd., Thomas & Betts Corporation, Calpipe Industries, Inc., TE Connectivity LtdOglaend System Group, Marco Cable Management and Eaton Corporation among others are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Apr 2016
Category:  Chemicals
Report ID:   57809
Report Format:   PDF
Pages:   120
Rating:    4.3 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support